Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.31 USD | +7.91% | +17.17% | +299.30% |
Apr. 25 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
Apr. 24 | Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 8.19B |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -172M | EV / Sales 2024 * | - |
Net cash position 2024 * | 895M | Net cash position 2025 * | 749M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-66.5
x | P/E ratio 2025 * |
-48
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.93% |
Latest transcript on Viking Therapeutics, Inc.
1 day | +7.91% | ||
1 week | +17.17% | ||
Current month | -9.38% | ||
1 month | -10.84% | ||
3 months | +247.73% | ||
6 months | +704.22% | ||
Current year | +299.30% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 74.31 | +7.91% | 3,535,445 |
24-04-25 | 68.86 | +5.82% | 3,526,931 |
24-04-24 | 65.07 | +0.22% | 2,584,595 |
24-04-23 | 64.93 | +1.69% | 2,032,588 |
24-04-22 | 63.85 | +0.68% | 1,562,386 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+299.30% | 8.19B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VKTX Stock